title: Evaluation of doripenem in an experimental model of resistant Pseudomonas aeruginosa pneumonia.
authors.forename: Cédric
authors.initials: C
authors.lastname: Bretonnière
authors.forename: Cédric
authors.initials: C
authors.lastname: Jacqueline
authors.forename: Jocelyne
authors.initials: J
authors.lastname: Caillon
authors.forename: Christophe
authors.initials: C
authors.lastname: Guitton
authors.forename: Cyndie
authors.initials: C
authors.lastname: Desessard
authors.forename: Virginie
authors.initials: V
authors.lastname: Le Mabecque
authors.forename: Anne Françoise
authors.initials: AF
authors.lastname: Miégeville
authors.forename: Daniel
authors.initials: D
authors.lastname: Villers
authors.forename: Gilles
authors.initials: G
authors.lastname: Potel
authors.forename: David
authors.initials: D
authors.lastname: Boutoille
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D058491:Bacterial Load; D015780:Carbapenems / Q000008:administration & dosage*; D015169:Colony Count, Microbial; D004195:Disease Models, Animal; D000077726:Doripenem; D006801:Humans; D015378:Imipenem / Q000008:administration & dosage; D008168:Lung / Q000382:microbiology; D000077731:Meropenem; D018410:Pneumonia, Bacterial / Q000188:drug therapy*; D011552:Pseudomonas Infections / Q000188:drug therapy*; D011550:Pseudomonas aeruginosa / Q000187:drug effects*; D011817:Rabbits; D013845:Thienamycins / Q000008:administration & dosage; D016896:Treatment Outcome; D018440:beta-Lactam Resistance
chemical_list: D000900:Anti-Bacterial Agents; D015780:Carbapenems; D013845:Thienamycins; D015378:Imipenem; D000077726:Doripenem; D000077731:Meropenem